BED: Uma Combinação com Etoposide, Bleomicina e Cisplatinum Efetiva em Tumores Germinativos Não-Seminomatosos Disseminados de Testículo

Authors

  • Milton Rabinowits Serviço de Oncologia Clínica, Instituto Nacional de Câncer. Rio de Janeiro (RJ), Brasil.
  • Carlos Augusto V. de Andrade Serviço de Oncologia Clínica, Instituto Nacional de Câncer. Rio de Janeiro (RJ), Brasil.

DOI:

https://doi.org/10.32635/2176-9745.RBC.1987v33n4.3222

Keywords:

Testis Tumors, Chemotherapy, Etoposide

Abstract

A total of 21 patients (pts) with nonseminomatous germ cell tumors of testis have been treated from october 1981 to october 1983, with a drug combination (BED) using etoposide (VP16) substituted for vinblastine (VLB), in combination with bleomycin (BLM) and cisplatin (DDP), in order to decrease toxicity and get better results. Complete remission (CR) was obtained in 15 (71 %), and there was no residual disease at surgery, in 4 of the remaining 6pts, with a favorable response (FR) in 19 (90%); 14 pts (67%) have remained alive without disease (WD) for 12-48 months (median 26 months). Pts with minimal disease (5) presented 100% of CR without rela pse. Pts with moderate and advanced disease presented FR: 86 and 89%, with only 5/and 44 % remaining WD, respectively. Three pts presented lung toxicity in the group with DDP preceding BLM (16pts). There was no episode of leukopenic fever or mucositis and muscle pain so frequent with VLB. BED is less toxic, but change of the sequence, avoiding the use of DDP preceding BLM is necessary, in order to prevent new cases of BLM lung toxicity lts effectivity, similar to regimens with VLB, BLM and DDP recommend BED to pts with minimal disease, as well as to evaluate more effective combinations when dealing with poor prognosis disease.

Downloads

Download data is not yet available.

References

Einhorn LH Testicular cancer as a model for a curable neoplasm. the Richard and Hinda Rosenthal Foundation Award Leclure. Cancer Res, 1981; 41: 3276-3280.

Bosi GJ, Gluckman R, Gelier NL, et al. - VA13-6 an effective cbemotherapy regimen for patients with germ-ceil tumors. J Clin Oncoi, 1986; 4.1493-1499. DOI: https://doi.org/10.1200/JCO.1986.4.10.1493

Peckham MJ, Barrett A, Liew KH, et al. - The treatment of metastalic germ-cell testicular tumors with bleomycin, etoposide and cisplatin (BED). Brit J Cancer, 1983, 47:613-619. DOI: https://doi.org/10.1038/bjc.1983.99

Wettlaufer JN, Feiner AS and Robinson WA - Vincristine, cispiatin and bleomycin with surgery is lhe management of advanced metastatic nontemiromatous testis tumors. Cancer, 1984; 53:203-209. DOI: https://doi.org/10.1002/1097-0142(19840115)53:2<203::AID-CNCR2820530203>3.0.CO;2-U

Bircb A, Williams SD, Cone A et al. - Prognostic facturo fca ravorable outcome in disseminated germ cell tumors J Chn Oncol, 1986; 4:400-407. DOI: https://doi.org/10.1200/JCO.1986.4.3.400

Bosi GL, GeHer N L, Cirrinciore C et al. Muitivanate analysis of prognostic variables in patients with metastatic testicuiar cancer. Cancer Res, 1983; 43: 3403-3407

Peckham MJ, Ohver RTD, Bagshawe KD et al - Prognostic factors in advanced nonseminomatous germ-cell testicuiar tumors: Resuits of a muiticentre study. LanceI, 1985; 1:8-11, DOI: https://doi.org/10.1016/S0140-6736(85)90963-8

Stoter G, Vendnk CPJ, Struyenberg A et al. -- Five-year survival of patients with disseminated nonseminomatous lenticular cancer treated with cispiatin, vinblastine and bieomycin. Cancer, 1984; 54.1521-1524. DOI: https://doi.org/10.1002/1097-0142(19841015)54:8<1521::AID-CNCR2820540808>3.0.CO;2-8

Einhorn LH, Donohue J - Cis-diammine cicloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ass Intem Med, 1977; 293-298 DOI: https://doi.org/10.7326/0003-4819-87-3-293

Williams SD, Einhorn LH, Greco FA et al. VP-16-213 salvage chemotherapy for refractory germinal neoplasms. Cancer, 1980, 4h 2154-2158. DOI: https://doi.org/10.1002/1097-0142(19801115)46:10<2154::AID-CNCR2820461008>3.0.CO;2-3

Bosi GJ, Yagoda A, Whitmore E et al, - Role of etoposide-based chemolherapy to the treatment of patients with refractory or relapsing germ cell tumors, Am J Med, 1985; 423-428 DOI: https://doi.org/10.1016/0002-9343(85)90333-X

Logolhetis CJ, Samuels ML, Trindade A et al. - The prognostic significance of endodermal sinus tumor histology amorrg patients treated for stage II non-seminomatous germ cell tumors of testes. Cancer, 1984, 53.122-128 DOI: https://doi.org/10.1002/1097-0142(19840101)53:1<122::AID-CNCR2820530122>3.0.CO;2-B

Javadpour N, Mcintee KR and Waidnrann IA - Human chorionic gonadotropin lHCGi and alpha-fetoprotein (AFP) lo sera and tumor cells of patients with testicular teminoma - a prospectiva study. Cancer, 1978; 42:2768-2772. DOI: https://doi.org/10.1002/1097-0142(197812)42:6<2768::AID-CNCR2820420636>3.0.CO;2-Z

Kaplan EL, Meier P - Non parametric estimation for incomplete obtervations .J Am Stat Assoc, 1958; 53: 457-481. DOI: https://doi.org/10.1080/01621459.1958.10501452

Gehan EA - A generalized Wiicoxon leal for comparing arbitrariiy singly-censored samples. Biomelrika, 1965, 52:203-223 DOI: https://doi.org/10.2307/2333825

Williams S, Einhorn LH and Greco A Disseminated germ-cei tumors A comparison of cisplalin plus bleomycin plus eithervinbiastine (PVB) or VP-16 (BED). Proc Am Soc Cio Oncoi, 1985; 4:100.

Logothetis CJ, Samueis ML, Selig D et al - Improved survival with cyclic chemothemapy for nonseminomatous germ ceii tumors of lhe testis. J Cm Oscol, 1985; 3:325-326 DOI: https://doi.org/10.1200/JCO.1985.3.3.326

Ozols RF, Corden BJ, Jacob J et al High dose cisplatin to hypertonic saine. Ano ml Med, 1984; 100.19-24. DOI: https://doi.org/10.7326/0003-4819-100-1-19

Ozols RF, Deisseroth AR, Javadpour N et al - treatment of poor prognosis non-seminomatous testicuiar cancer with a "high-dose'' plasinum combination chemotherapy regimen. Cancer, 1983; 51:1803-1807. DOI: https://doi.org/10.1002/1097-0142(19830515)51:10<1803::AID-CNCR2820511008>3.0.CO;2-F

Ozols RF, ihde 0, Jacob J et al. - Randomized triai of PVeBV [high dose (HD) cisplatin (P), vinblastine (Ve), bleomycin (B), VP-16 (V)] versus PVeBV in poor prognosis non-seminomatous testcuiar cancer (NSTC). Proc Am Soc Cm Oncol, 1984; 3:155.

Dalgleish AG, Woods RL and Levi JA - Bleomycin pulmonary toxicity: Is relationship to renal dysfunction. Med Ped Oncol, 1984; 12.313-317. DOI: https://doi.org/10.1002/mpo.2950120503

Rabinowits M, Gil RA, Andrade CA et al. - Serious lung toxicity with combinations of drugs containing cisplatinum preceding bleomycin. Abst Lect Symp Free Com 14th Int Cancer Congress, 1986; 2: 753.

Published

2023-08-03

How to Cite

1.
Rabinowits M, Andrade CAV de. BED: Uma Combinação com Etoposide, Bleomicina e Cisplatinum Efetiva em Tumores Germinativos Não-Seminomatosos Disseminados de Testículo. Rev. Bras. Cancerol. [Internet]. 2023 Aug. 3 [cited 2024 Dec. 23];33(4):341-6. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/3222

Issue

Section

ORIGINAL ARTICLE

Most read articles by the same author(s)